Ren Yi (仁怡)仁怡
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 南京正大天晴制药有限公司Chinese legal name: 南京正大天晴制药有限公司
主要成分Active Ingredients
- 帕米膦酸二钠Pami Linsuan Erna
- 葡萄糖Putao Tang
- 帕米膦酸二钠和葡萄糖Pami Linsuan Erna Hepu Taotang
药物知识说明
帕米膦酸二钠是一种在国家药监局注册认定的药品。该药品含有帕米膦酸二钠、葡萄糖-31b6cd73等成分。
该药品关联的活性成分包括：帕米膦酸二钠Pami Linsuan Erna、葡萄糖Putao Tang。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：南京正大天晴制药有限公司Chinese legal name: 南京正大天晴制药有限公司。
您可以探索含有相同成分的其他药品：帕米膦酸二钠-c05758c5成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 仁怡) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 帕米膦酸二钠Pami Linsuan Erna, 葡萄糖Putao Tang.
Manufacturers recorded for this product: 南京正大天晴制药有限公司Chinese legal name: 南京正大天晴制药有限公司.
Explore other medicines containing the same ingredient: 帕米膦酸二钠 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 仁怡Recorded Chinese name: 仁怡
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 250ml:30mg帕米膦酸二钠（按无水物计）和12.5g葡萄糖。Recorded Chinese description: 250ml:30mg帕米膦酸二钠（按无水物计）和12.5g葡萄糖。
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 南京正大天晴制药有限公司Chinese legal name: 南京正大天晴制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20041166
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20041166
Manufacturer
Chinese legal name: 南京正大天晴制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20041166
生产企业
南京正大天晴制药有限公司(国产)
适应症
恶性肿瘤并发的高钙血症和溶骨性癌转移引起的骨痛。
用法用量
缓慢静脉滴注。治疗骨转移性疼痛:每次250ml或遵医嘱，滴速不得大于30mg/2小时，一次用药30～60mg。|治疗高钙血症:应严格按照血钙浓度，在医生指导下酌情用药。
不良反应
少数病人可出现轻度恶心、胸痛、胸闷、头晕乏力及轻微肝肾功能改变等，偶见发热反应。
禁忌
对本品或其他双膦酸类药物有过敏史者禁用。
注意事项
1.肾功能损伤或减退者慎用； |2.用于治疗高钙血症时，应同时注意补充液体，使每日尿量达2L以上； |3.使用本品过程中，应注意监测血清钙、磷等电解质水平； |4.本品应保存在儿童不能触及的地方； |5.本品不得与其他种类双膦酸类药物合并使用。
贮藏
遮光密闭，室温(10-30℃)保存。
规格
250ml:30mg帕米膦酸二钠（按无水物计）和12.5g葡萄糖。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.